We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Jul 20
INO-4800 is a DNA vaccine candidate being developed to protect against the novel coronavirus SARS-CoV-2, which causes Covid-19
22 Jun 20
Clover will begin phase 1 study of GSK’s Covid-19 S-Trimer vaccine (SCB-2019) in combination with GSKs pandemic adjuvant…
19 Jun 20
The study showed improvement in pathological complete response (pCR) for the treatment of people with early triple-negative breast…
The FDA has cited evidence of serious side-effects including cardiac-adverse events in patients given chloroquine drugs to treat…
12 Jun 20
Moderna has finalised a protocol for the Phase 3 randomised, placebo-controlled clinical study, based on the US FDA…
09 Jun 20
Junshi Biosciences is carrying out the development of the investigational medicine in Greater China, while Lilly is leading…
08 Jun 20
Calquence has reduced inflammation and improved clinical outcomes in 19 hospitalised patients with Covid-19 disease and severe hypoxia…
03 Jun 20
CFI-402411 is a potential HPK1 inhibitor that has demonstrated immune-activating effects and cytotoxic effects in preclinical studies
02 Jun 20
The study is a randomised, placebo-controlled, double-blind Phase 1 clinical trial that evaluates the safety, tolerability of LY-CoV555
It would be "very, very difficult" to conduct a UK-wide Covid-19 clinical trial quickly enough without IQVIA's overarching…